Treatment of acute myocardial infarction in pregnancy with coronary artery balloon angioplasty and stenting: use of tirofiban and clopidogrel.
Acute myocardial infarction (AMI) in pregnancy is rare and has a high mortality rate of 37-50%. The most important risk factors are advanced maternal age, hypertension and diabetes mellitus. Although thrombolytic therapy, percutaneous transluminal coronary angioplasty (PTCA) and coronary artery by-pass grafting can be performed, primary PTCA and antiplatelet agents have recently improved prognosis. We here present a case of AMI in a 43 year old woman in the 20th week of pregnancy treated successfully with aspirin, clopidogrel and intracoronary stenting without any complications.
Boztosun
Bilal
B
Olcay
Ayhan
A
Avci
Anil
A
Kirma
Cevat
C
D000328:Adult; D015906:Angioplasty, Balloon, Coronary / Q000295:instrumentation / Q000379:methods*; D000077144:Clopidogrel; D004359:Drug Therapy, Combination; D054855:Drug-Eluting Stents; D005260:Female; D006801:Humans; D009203:Myocardial Infarction / Q000503:physiopathology / Q000628:therapy*; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000503:physiopathology / Q000628:therapy*; D013988:Ticlopidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000077466:Tirofiban; D014443:Tyrosine / Q000008:administration & dosage / Q000031:analogs & derivatives*
D014443:Tyrosine; D000077144:Clopidogrel; D000077466:Tirofiban; D013988:Ticlopidine